Prevention of drug-induced programmed and unprogrammed cell death by citrus flavonoids

被引:0
|
作者
Ray, Sidhartha D. [1 ]
Zinkovsky, Daniel [1 ]
Bulku, Ellida [1 ]
Patil, Bhimanagouda S. [1 ]
机构
[1] Long Isl Univ, Mol Toxicol Labs, Div Pharmaceut Sci, Arnold & Marie Schwartz Coll Pharm & Hlth Sci, Brooklyn, NY 11201 USA
来源
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Cell life and cell death in vivo are delicately balanced and linked processes dependent upon several "death" or "survival" signals from inside and outside the cell. These signals are regulated by several vital intracellular events associated with DNA, RNA, caspases, proteins, and ions. Drugs and other chemicals are known to threaten the stability of such key intracellular molecules by causing ion deregulation, oxidative stress, DNA fragmentation and activation of caspases. Citrus flavonoids, such as hesperidin (HES) and rutin (RUT), are known to specifically interfere with such deleterious pathways, minimize macromolecular perturbations, and exhibit their prolific antitoxic properties. This study was designed to investigate whether HES and RUT pre-exposures (1.25g/kg orally for 14 days) have the ability to counteract hepatotoxicity and nephrotoxicity induced by toxic doses of acetaminophen (APAP, 500 mg/kg, ip) and diclofenac (DCLF, 200 mg/kg, po) respectively in vivo. Additional objectives were to determine whether exposure to these flavonoids protect the liver and kidneys from oxidative stress and genomic DNA fragmentation, the prime players responsible for turning on various forms of cell death. Results indicate that HES and RUT pre-exposures showed dramatic prevention of hepato- and nephrotoxicity by minimizing toxicant-induced oxidative stress and genomic DNA fragmentation which are instrumental in orchestrating apoptotic (programmed) and necrotic (unprogrammed) cell deaths in these organs in vivo.
引用
收藏
页码:144 / 160
页数:17
相关论文
共 50 条
  • [41] Drug-induced uveitis - Incidence, prevention and treatment
    Fraunfelder, FW
    Rosenbaum, JT
    DRUG SAFETY, 1997, 17 (03) : 197 - 207
  • [42] Drug-Induced Renal CalculiEpidemiology, Prevention and Management
    Michel Daudon
    Paul Jungers
    Drugs, 2004, 64 : 245 - 275
  • [43] Drug-Induced Thrombotic MicroangiopathyIncidence, Prevention and Management
    Roberto Pisoni
    Piero Ruggenenti
    Giuseppe Remuzzi
    Drug Safety, 2001, 24 : 491 - 501
  • [44] DETECTION AND PREVENTION OF DRUG-INDUCED BLOOD DYSCRASIAS
    ERSLEV, AJ
    WINTROBE, MM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1962, 181 (02): : 114 - &
  • [45] Drug-induced delirium - Incidence, management and prevention
    Carter, GL
    Dawson, AH
    Lopert, R
    DRUG SAFETY, 1996, 15 (04) : 291 - 301
  • [47] RECOGNITION PREVENTION AND TREATMENT OF DRUG-INDUCED HEPATITIS
    POPPER, H
    MODERN TREATMENT, 1969, 6 (01): : 142 - &
  • [48] MicroRNAs in the diagnosis and prevention of drug-induced cardiotoxicity
    Skala, Mikulas
    Hanouskova, Barbora
    Skalova, Lenka
    Matouskova, Petra
    ARCHIVES OF TOXICOLOGY, 2019, 93 (01) : 1 - 9
  • [49] Drug-Induced Pancreatitis Incidence, Management and Prevention
    Balani, Anil R.
    Grendell, James H.
    DRUG SAFETY, 2008, 31 (10) : 823 - 837
  • [50] DRUG-INDUCED PARKINSONISM IN THE AGED - RECOGNITION AND PREVENTION
    GERSHANIK, OS
    DRUGS & AGING, 1994, 5 (02) : 127 - 132